ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,708.89
-0.81%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Allogene Therapeutics Inc (ALLO) Share Price

ALLO Allogene Therapeutics Inc

2.52
-0.02 (-0.79%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Allogene Therapeutics Inc NASDAQ:ALLO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.02 -0.79 2.52 2.53 2.65 2.59 2.465 2.53 1,747,944 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 95k -327.27M -1.9354 -1.31 427.8M
 Type  Size  Price  Time  Units 
 9 3 2.52 23:55:39 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ALLO News
23/05/202413:30GLOBEAllogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
14/05/202421:40EDGAR2Form 8-K - Current report
14/05/202421:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/05/202421:47GLOBEAllogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
13/05/202421:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/05/202421:02EDGAR2Form 8-K - Current report
13/05/202421:01GLOBEAllogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
Period
Draw mode
Data Downloads for ALLO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Allogene Therapeutics Inc Articles